BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 8575482)

  • 41. Improved detection of myocardial perfusion reversibility by rest-nitroglycerin Tc-99m-MIBI: comparison with TI-201 reinjection.
    Batista JF; Pereztol O; Valdés JA; Sánchez E; Stusser R; Rochela LM; López D; Garcia EV
    J Nucl Cardiol; 1999; 6(5):480-6. PubMed ID: 10548142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Comparison of technetium 99m methoxy isobutyl isonitrile and thallium 201 for evaluation of coronary artery disease by planar and tomographic methods.
    Kiat H; Maddahi J; Roy LT; Van Train K; Friedman J; Resser K; Berman DS
    Am Heart J; 1989 Jan; 117(1):1-11. PubMed ID: 2643279
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic value of technetium-99m-MIBI as a myocardial perfusion imaging agent: comparison of long and short intervals between rest and stress injections.
    Magriñà J; Bosch X; Garcia A; Pons F; Moragas M; Roig E; Navarro Lopez F; Setoain J
    Clin Cardiol; 1992 Jul; 15(7):497-503. PubMed ID: 1499174
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Reverse redistribution in resting thallium-201 myocardial scintigraphy in patients with coronary artery disease: relation to coronary anatomy and ventricular function.
    Pace L; Cuocolo A; Maurea S; Nicolai E; Imbriaco M; Nappi A; Morisco C; Chiariello M; Trimarco B; Salvatore M
    J Nucl Med; 1993 Oct; 34(10):1688-92. PubMed ID: 8410282
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Relation between dobutamine trans-thoracic echocardiography, 99Tcm-MIBI and 18FDG uptake in chronic coronary artery disease.
    Lucignani G; Landoni C; Mengozzi G; Palagi C; Paolini G; Zuccari M; Vanoli G; Biadi O; Mariani MA; Mariani M
    Nucl Med Commun; 1995 Jul; 16(7):548-57. PubMed ID: 7478392
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Positron emission tomography detects evidence of viability in rest technetium-99m sestamibi defects.
    Sawada SG; Allman KC; Muzik O; Beanlands RS; Wolfe ER; Gross M; Fig L; Schwaiger M
    J Am Coll Cardiol; 1994 Jan; 23(1):92-8. PubMed ID: 8277101
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prediction of improvement of regional left ventricular function after revascularization using different perfusion-metabolism criteria.
    Bax JJ; Visser FC; Elhendy A; Poldermans D; Cornel JH; van Lingen A; Boersma E; Sloof GW; Fioretti PM; Visser CA
    J Nucl Med; 1999 Nov; 40(11):1866-73. PubMed ID: 10565782
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Thallium reinjection demonstrates viable myocardium in regions with reverse redistribution.
    Marin-Neto JA; Dilsizian V; Arrighi JA; Freedman NM; Perrone-Filardi P; Bacharach SL; Bonow RO
    Circulation; 1993 Oct; 88(4 Pt 1):1736-45. PubMed ID: 8403320
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Identification of viable myocardium in patients with chronic coronary artery disease: comparison of thallium-201 scintigraphy with reinjection and technetium-99m-methoxyisobutyl isonitrile.
    Cuocolo A; Pace L; Ricciardelli B; Chiariello M; Trimarco B; Salvatore M
    J Nucl Med; 1992 Apr; 33(4):505-11. PubMed ID: 1552332
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparison of 99mTc-hexakis 2-methoxy-2-isobutyl isonitrile and 201Tl SPECT imaging for evaluation of coronary artery disease].
    Takahashi N; Tamaki N; Ohtani H; Shindo M; Kawamoto M; Yonekura Y; Ono S; Nohara R; Kambara H; Kawai C
    Kaku Igaku; 1991 Sep; 28(9):1021-7. PubMed ID: 1837570
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Reversibility in perfusion scintigraphy after myocardial infarct: a comparison between the protocol of single-day rest-stress with 99mTc sestamibi and reinjection with thallium-201].
    Ferreira J; Gil VM; Ventosa A; Calqueiro J; Seabra-Gomes R
    Rev Port Cardiol; 1993 Dec; 12(12):1013-21, 999. PubMed ID: 8117454
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Myocardial viability assessment with technetium-99m-tetrofosmin and thallium-201 reinjection in coronary artery disease.
    Matsunari I; Fujino S; Taki J; Senma J; Aoyama T; Wakasugi T; Hirai J; Saga T; Ichiyanagi K; Hisada K
    J Nucl Med; 1995 Nov; 36(11):1961-7. PubMed ID: 7472582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Septal glucose metabolism in patients with coronary artery disease and left bundle-branch block.
    Altehoefer C; vom Dahl J; Buell U
    Coron Artery Dis; 1993 Jun; 4(6):569-72. PubMed ID: 8261236
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Rest myocardial perfusion/metabolism imaging using simultaneous dual-isotope acquisition SPECT with technetium-99m-MIBI/fluorine-18-FDG.
    Delbeke D; Videlefsky S; Patton JA; Campbell MG; Martin WH; Ohana I; Sandler MP
    J Nucl Med; 1995 Nov; 36(11):2110-9. PubMed ID: 7472607
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Segmental analysis of SPECT 99mTc-methoxy isobutyl isonitrile and 201Tl myocardial imaging in ischaemic heart disease.
    Hassan IM; Mohammed MM; Constantinides C; Sadek S; Nair M; Belani N; Yousef AM; Abdel-Dayem HM
    Eur J Nucl Med; 1990; 16(8-10):705-11. PubMed ID: 2384106
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparison of SPECT using technetium-99m agents and thallium-201 and PET for the assessment of myocardial perfusion and viability.
    Berman DS; Kiat H; Van Train KF; Friedman J; Garcia EV; Maddahi J
    Am J Cardiol; 1990 Oct; 66(13):72E-79E. PubMed ID: 2145750
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Time dependence of residual tissue viability after myocardial infarction assessed by [18F]fluorodeoxyglucose and positron emission tomography.
    Fragasso G; Chierchia SL; Lucignani G; Landoni C; Conversano A; Gilardi MC; Colombo F; Rossetti C; Fazio F
    Am J Cardiol; 1993 Dec; 72(19):131G-139G. PubMed ID: 8279350
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Comparison of technetium-99m sestamibi left ventricular wall motion and perfusion studies with thallium-201 perfusion imaging: in search of the combination of variables with the highest accuracy in predicting coronary artery disease.
    Verzijlbergen JF; Zwinderman AH; Ascoop CA; van der Wall EE; Niemeyer MG; Pauwels EK
    Eur J Nucl Med; 1996 May; 23(5):550-9. PubMed ID: 8698061
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical comparison between thallium-201 and Tc-99m-methoxy isobutyl isonitrile (hexamibi) myocardial perfusion imaging for detection of coronary artery disease.
    Taillefer R; Lambert R; Dupras G; Grégoire J; Léveillé J; Essiambre R; Phaneuf DC
    Eur J Nucl Med; 1989; 15(6):280-6. PubMed ID: 2527750
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of myocardial viability assessed by technetium-99m-sestamibi SPECT and fluorine-18-FDG PET on clinical outcome in coronary artery disease.
    vom Dahl J; Altehoefer C; Sheehan FH; Buechin P; Schulz G; Schwarz ER; Koch KC; Uebis R; Messmer BJ; Buell U; Hanrath P
    J Nucl Med; 1997 May; 38(5):742-8. PubMed ID: 9170439
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.